ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents

ClinicalTrials.gov ID: NCT02740660

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02740660. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 6:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect on Body Composition With Albuterol and Caffeine Versus Placebo in Adolescents: A Pilot Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether taking a combination of caffeine and albuterol three times per day will increase muscle and decrease fat in your child's body and to determine how these medications make your child feel. Albuterol is approved by the FDA for the treatment of asthma. It is not approved to increase muscle and decrease body fat in children.

Study identification

NCT ID: NCT02740660
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Pennington Biomedical Research Center; Other
Enrollment: 12 participants

Conditions and interventions

Conditions

Pediatric Obesity

Interventions

Caffeine 100mg / Albuterol 4mg Drug
Placebo Drug
Family weight management counseling Behavioral

Drug · Behavioral

Eligibility (public fields only)

Age range: 12 Years to 17 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2016 (Type not available)
Primary completion: Oct 24, 2017 (Actual)
Completion: Oct 31, 2017 (Actual)
Last update posted: Oct 8, 2019

2016 – 2017

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Pennington Biomedical Research Center	Baton Rouge	Louisiana	70808-4124	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02740660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 8, 2019 · Synced Nov 12, 2026